Yüklüyor......
Developing a Canadian Real-World Evidence Action Plan across the Drug Life Cycle
Policy makers face challenges with the number of drugs for rare indications and rapidly rising costs. In facing these challenges, decision-makers see real-world evidence (RWE) as an opportunity. Health Canada and the Canadian Agency for Drugs and Technologies in Health (CADTH) recently announced the...
Kaydedildi:
| Yayımlandı: | Healthc Policy |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Longwoods Publishing
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7294449/ https://ncbi.nlm.nih.gov/pubmed/32538348 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12927/hcpol.2020.26225 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|